Latest news with #Telehealth
Globe and Mail
15-07-2025
- Health
- Globe and Mail
Telehealth Market & Telemedicine Market to Hit USD 180.86 Billion by 2030 with 11.5% CAGR
Browse 548 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on "Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030 The Telehealth Market & Telemedicine market valued at US$ 83.62 Billion in 2023, is forecasted to grow at a robust CAGR of 11.5%, reaching US$ 94.14 Billion in 2024 and an impressive US$ 180.86 Billion by 2030. The telehealth and telemedicine market are experiencing significant growth primarily driven by the growing geriatric and medically underserved (especially rural) populations, the growing prevalence of chronic conditions, the benefits of telehealth & telemedicine given the current shortage of physicians and care personnel, and advancements in telecommunication technologies, and expansion of remote patient monitoring (RPM) systems. However, regulatory variations across regions, the rise in fraud and abuse within healthcare systems, and behavioural reluctance to adopt new technologies are expected to restrain the market growth during the forecast period. Download PDF Brochure: Browse in-depth TOC on " Telehealth Market & Telemedicine Market" 350 - Tables 50 - Figures 400 - Pages Government initiatives to improve access to healthcare also play a vital role, often providing funding and resources to strengthen telehealth infrastructure, especially in underserved regions. Collaboration between technology firms and healthcare delivery organizations is a very important determinant that will have innovative solutions towards enhancing service delivery and engaging the patient to improved health outcomes. Together, these determinants drive growth in the market and change the face of the healthcare delivery scene to become responsive to patient needs and preferences. By component, the software component is expected to capture the largest share of telehealth & telemedicine market during the forecast period. This would be due to the increasing demand for the digital health solution, which could be used for remote consultations, monitoring, and patient management. The software segment includes different tools and platforms, such as electronic health records (EHR), telemedicine applications, and patient management systems, which are important for providing virtual healthcare services. The product will increase productivity in the hands of healthcare providers through proper communication, real-time tracking of information, and inclusion into other service offerings. Moreover, the cloud-based platform and AI machine learning in application software also support their adoption by enriching the features of diagnosis, treatment plans, and predictive analytics. The healthcare systems that are increasingly adopting digital transformation will be dominated by software solutions in terms of scalability, flexibility, and improved patient outcomes. By Age group, adults segment is dominated the telehealth & telemedicine market. This is due to the steadily rising prevalence rate of chronic diseases and the growing desire for healthcare care among adults. Adults, especially those above age 40, normally require regular and continued monitoring management of conditions for diabetes, high blood pressure as well as cardiovascular-related diseases, which telehealth can be very useful. Telemedicine is easy and convenient for adults to access healthcare services without the need for frequent in-person visits, which is very helpful for people with mobility issues, busy schedules, or limited access to healthcare facilities. Moreover, adults are more likely to embrace technology and use digital health solutions for managing their health, thus contributing to the dominance of the segment in the telehealth and telemedicine market. The major players in the telehealth & telemedicine market with a significant global presence are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), Cisco Systems Inc. (US), Included Health, Inc. (Doctor on Demand, Inc.) (US), AMC Health (US), TeleSpecialists (US), Walgreen Co. (US), Caregility (US), CVS Health (US), EverNorth Health, Inc. (US), Elation (US), Iron Bow Healthcare Solutions (US), and Zoom Communications, Inc. (US), Timedoc Health (US), Cerebral Inc. (US), Kindbody (US), Transcarent (US), and Caresimple, Inc. (US). The market players have adopted strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals to strengthen their position in the telehealth & telemedicine market. The product and technology innovations have helped the market players expand globally by providing telehealth & telemedicine solutions. These players not only have a comprehensive and diverse product portfolio but also a strong geographic presence. With the increasing adoption of telehealth and telemedicine in various healthcare applications, these players can focus on developing innovative virtual care platforms and adaptive trial design advanced remote patient monitoring solutions, and integrated telemedicine services. These market players offer a diverse range of products and services worldwide. They rely on technological advancements to develop innovative products and services and increase their global footprint. Increasing focus on acquisitions, collaborations, partnerships, mergers, product/service launches and enhancements, and approvals, facilitate the market players to expand their global reach and develop advanced telehealth & telemedicine solutions to sustain their market positions. Koninklijke Philips N.V Koninkliike Philips N.V. is a diversified technology-based company in the healthcare and consumer lifestyle markets. It is one of the leading companies in the healthcare sector with a strong presence in cardiac care, acute care, and home healthcare. The company operates through four segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The telehealth and telemedicine services fall under the connected care segment. The connected care segment consists of following business's monitoring, sleep & respiratory care and enterprise informatics. The telehealth solutions are used by providers and patients. The company operates in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In November 2024, Philips has received FDA approval for remote scanning and protocol management features in its Radiology Operations Command Centre (ROCC), allowing radiologists to assist with scans remotely. In January 2023, Philips and Masimo expanded their partnership to enhance telehealth by integrating the Masimo W1 health-tracking watch with Philips' monitoring systems for better patient care at home. Medtronic Medtronic is one of the largest medical technology, services, and solutions companies globally. The company operates through four principal segments, namely, Cardiovascular, Diabetes, Medical Surgical, and Neuroscience. The company extends telehealth solutions across all four segments. Within the Cardiac and Vascular segment, it offers products and services to diagnose, treat, and manage cardiac rhythm disorders and cardiovascular diseases. Medtronic's portfolio encompasses remote monitoring platforms and patient-cantered software through its products and Medtronic Care Management Services. The telehealth solutions offered by the company cover glucose management and cardiac condition management. Medtronic's telehealth device offerings include Bluetooth-enabled and direct-connect peripherals. These devices comprise weight scales, glucometers, blood pressure monitors, pulse oximeters, pedometers, and activity trackers. Medtronic serves its customers in ~160 countries worldwide. The company operates in North America, Latin America, Europe, Asia Pacific, Middle East and Africa and Russia. Epic Systems Corporation Epic Systems is a software development, installation, and support company that also provides consulting services. The company establishes healthcare management software that combines financial and clinical information from inpatient, ambulatory, and payer technology systems. The company's core competency is to provide EHR software solutions. Epic Systems Corporation is integrating Al into telehealth and telemedicine through strategic partnerships with Microsoft and generative Al technologies. Epic aims to improve productivity and patient care in virtual healthcare settings by combining its EHR solutions with Microsoft's Azure OpenAl Service. This encompasses improving workflows, enabling generative Al to compose message responses, and supporting natural language queries. Epic's Al efforts also focus on enhancing self-service reporting tools, maintaining financial integrity, and improving clinical outcomes, all of which will enhance global telehealth and telemedicine systems. It operates its offices in the US, UK, Canada, Denmark, the Netherlands, Norway, Saudi Arabia, the UAE, Finland, Ireland, Australia, Singapore, and Switzerland. For more information, Inquire Now!
Yahoo
25-06-2025
- Business
- Yahoo
Why Hims & Hers Health Stock Is Crashing Today
Novo Nordisk is ending its relationship with the company, removing its ability to sell the uber-popular drug Wegovy. Novo alleges Hims & Hers was not following standards and was endangering patient safety. 10 stocks we like better than Hims & Hers Health › Shares of Hims & Hers Health (NYSE: HIMS) are imploding on Monday, down 32% as of 3:03 p.m. ET. The drop comes as the S&P 500 rose 0.8% and the Nasdaq Composite rose 0.7%. Novo Nordisk announced it will cut ties with Hims & Hers, saying the telehealth provider can no longer sell compounded versions of its blockbuster GLP-1 weight loss drug Wegovy. Novo Nordisk announced this morning that it is ending a partnership with Hims & Hers that allowed the telehealth provider to sell Novo's blockbuster weight-loss drug, Wegovy. According to Novo Nordisk, Hims & Hers "failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization.'" Hims & Hers offered compounded versions of Wegovy, claiming it offered medically necessary personalization for some patients. The compounded versions, according to Novo, were sourced out of China and the labs producing them failed to meet standards or be approved by U.S. regulators. In a statement on X, Hims & Hers CEO Andrew Dudum said the company is "disappointed to see Novo Nordisk management misleading the public" and that it would "not compromise the integrity of our platform to appease a third party." The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock reflects this, but even after falling more than 30%, the stock is still too expensive for my taste. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Why Hims & Hers Health Stock Is Crashing Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-06-2025
- Business
- Yahoo
Oscar Health soars, Kroger outlook, Couchbase deal: Trending Tickers
Here are some of the stocks on the move on Friday, June 20. Shares of Oscar Health (OSCR) are continuing to rise. The stock is up about 50% over the past 5 days. Kroger (KR) is seeing its stock jump after raising its full-year sales forecast and holding its profit outlook steady. Couchbase (BASE) shares are exploding higher on news that it was being acquired by Haveli Investments for $1.5 billion. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. Now time for some of today's trending tickers. Yahoo Finance's Josh Shafer, back with me now. We're going to be watching shares of Oscar Health, Kroger, and Couchbase all rising today's tray. I'm going to start with Oscar Health, it's up 50% over the last week and seeing its third day of consecutive gains driven by the bullishness of the insurance industry. Telehealth company reporting a 45% price increase since last quarter, due to the company's excellent first quarter earnings, and its growth is astounding, given the health insurance industry has been relatively flat recently. Additionally, a new proposal to create part of part E of Medicare, a voluntary self-funding plan, assisting in the rally for this stock, Josh. Yeah, Josh, the other side of this too, I think, is you're getting maybe just a little bit of a retail trader bid right now, right? So, volume in this stock has absolutely surged over the last couple days. There is a great article from Sherwood Media, Luke Kawa over there, highlighting that this has also been a popular stock on the Wall Street Bets Reddit account. And when you see moves in a stock like this, 50% in five days, and you and I look at our trending tickers page on Yahoo Finance frequently, you don't see Oscar Health a lot, Josh. And then all of a sudden it just comes out of nowhere, right? And I think it speaks to the conversation you and I were having earlier this week about sort of the momentum in the market that you're seeing in some of these names that just start to catch a bid, start to catch a bid, and then they're ripping higher, right? And I mean, not to compare this stock to Circle, but you're seeing it in a name like Circle. You're seeing it in the quantum computing stocks. You're seeing it in nuclear with UEC, which we talked about. So, I think it's a continuation of the theme that winners are winning right now and continuing to win. And there's clearly a retail trading bid in some of these names that just want to get in and try and chase it up a little bit because remember, we've said, the indexes aren't really doing a lot right now, right? If you're looking, if you're looking for some action, you got to go somewhere outside of this, the, yeah, outside of the major indexes. Also, Josh Kushner, Vice Chairman of this company, brother Jared Kushner. I'm just saying that, that, that can't, that can't hurt. You got friends in high places. That's all I'm saying. Yep. Also, Kroger, its stock rising after reporting a solid first quarter despite uncertainty we know in that industry. The grocery store chain sharing good earnings, same-store sales grew little over 2%. However, revenue fell short of estimates. Outlook for the year largely the same, slightly little weak according to analysts expectations. Kroger did raise its same-store sales guidance contributing to a largely mixed outlook for the remainder of the year, Josh. Yeah, Josh, I mean, you look at the stock over the last month, and it had not been necessarily outperforming by any means. I think it was probably in the red coming into today. So perhaps expectations had fallen just enough for a decent report to sort of give you that kind of pop, right? But I mean, always interesting when you see, to me, you always get the economic uncertainty comment now, right? That's like a given. You almost have to have it in your earnings release, I think, if you're going to put out earnings. You don't often get it though with the, economic outlook is uncertain, but we're boosting our sales forecast. I mean, if I'm an own, if I'm an owner of Kroger shares, and I'm hearing that, I'm feeling pretty good, right? There's obviously different headwinds going on with credit policy that could weigh on a business like this, and for them to say, you know what, we're addressing that. We understand that, but we're actually now seeing same-store sales in a range of 2 and 1/2 to 3, or 2 and 1/4 to 3 and 1/4%, instead of 2 to 3%. I'll take it. That's a solid print. So, the stock's up nearly 20% this year. I mean, what to do with it from here? Street's actually, just looking pretty divided. Got 12 buys, 11 holds, two sells. I don't know. Finally, Couchbase's stock. Let's check that one out. Soaring with the announcement that Havelli will acquire a company in a $1.5 billion acquisition. The deal between the software company and the investment firm, Havelli, will close in the second half of 25, Josh. Yeah, Josh, so this is not a couch company, right? They are more on the tech side of things. But I, what was interesting to me is, I was just looking at the long-term chart of the stock here. So, Couchbase went public in 2021 amid that IPO boom that we had in 2021. And then there's been a big question for a lot of these stocks is, well, what happens now several years later, right? These stocks. A lot of companies went public in 2021, a lot of them did not necessarily do great post 2021, right? So, Couchbase touched 50 bucks a share in the fall of 2021, and then pretty much never got close to it again. And so they had it caught a little bit of a bid in 2024, but it's run as a public company just has not been overall that successful for shareholders, at least that were in it at the beginning. So interesting to see the 2021, a 2021 IPO class stock getting bought to me. Yeah. And I did, I did see analysts at Wedbush just saying, good deal for both, strategic move for both entities, that these organizations closely aligned in terms of data and infrastructure build out. Data and infrastructure build out, Josh. Buzzwords, but what else do you need? Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Time of India
16-06-2025
- Business
- Time of India
Trump Mobile plan revealed: Here's how much it will cost subscribers for unlimited talk, text, and data
In a bold extension of its brand portfolio, the Trump Organization on Monday officially announced the launch of its new wireless service, Trump Mobile , alongside a branded smartphone priced at $499. The service is expected to go live in September 2025 and has already generated buzz through its political branding and pricing strategy. The move, anchored on a monthly subscription model titled 'The 47 Plan' , marks yet another instance of the Trump business empire tying commercial ventures to the political identity of U.S. President Donald Trump , who is currently serving his second term as the 47th President of the United States. Trump Mobile: Features and Pricing According to trumpmobile .com , the new mobile service will cost subscribers $47.45 per month and will include unlimited talk, text, and data , alongside additional features such as roadside assistance and a Telehealth and Pharmacy Benefit . The monthly rate and plan name are direct references to Trump's position as the 45th and now 47th U.S. President. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Walmart Faces Worst Nightmare As 87¢ ED Pill Takes Over Friday Plans Get Offer Undo Trump Mobile claims to provide network coverage equivalent to the nation's three largest wireless carriers — Verizon, AT&T, and T-Mobile — though representatives declined to specify which backend carrier powers the network, as mentioned in a report by NBC. The website further states that the service will offer U.S.-based customer support. However, when contacted, a customer service agent declined to reveal the exact location of the call center, citing 'security reasons.' Live Events Trump Phone: Gold-Toned 'T1' Device Unveiled Alongside the telecom plan, the Trump Organization announced the introduction of the Trump Phone , officially named the T1 . Priced at $499, the Android-based device reportedly comes with Android 15 OS , a 6.8-inch AMOLED screen , a 16-megapixel front camera , a 50-megapixel rear camera , 12GB of RAM , and 256GB of storage . The smartphone features a gold-colored metal frame etched with the American flag and branded slogans like 'Make America Great Again.' Licensing Model and Ethical Concerns Much like other Trump-branded merchandise — including Trump Bibles, sneakers, and wristwatches — the Trump Mobile venture operates under a licensing agreement . The fine print on the official website notes that neither the mobile service nor the smartphone is developed, manufactured, or sold directly by the Trump Organization or its affiliates. This model has drawn scrutiny from ethics watchdogs due to potential conflicts of interest, especially given President Trump's dual role as a business magnate and head of state. Notably, President Trump reported earnings exceeding $8 million in 2024 from various licensing arrangements. Market Comparison and Response While Trump Mobile's plan price point positions it at a premium, it appears costlier than several existing competitors. For instance, Visible by Verizon offers a similar unlimited plan at $25/month, and Mint Mobile has a comparable plan priced at $30/month over a 12-month term. As of Monday, the country's top wireless providers had not issued any public statements regarding the entry of Trumpmobile into the telecom space. With this strategic brand extension, the Trump Organization continues its trend of leveraging political capital into commercial ventures, setting the stage for what could be a high-profile addition to the U.S. mobile market. FAQs What is Trump Mobile? Trump Mobile is a new wireless service announced by the Trump Organization on Monday. It is a branded telecom venture offering unlimited talk, text, and data, with a subscription plan called 'The 47 Plan.' The service is expected to launch in September 2025. What network does Trump Mobile use? Trump Mobile claims to provide coverage equivalent to Verizon, AT&T, and T-Mobile, but has not disclosed which carrier powers its backend network. Customer service representatives declined to confirm the provider, citing security reasons.
Yahoo
06-06-2025
- Health
- Yahoo
Dr. Louis Krenn Medical Scholarship Invites Aspiring Physicians to Shape the Future of Healthcare
Dr. Louis Krenn SPRINGFIELD, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- The Dr. Louis Krenn Medical Scholarship announces a new opportunity for undergraduate and medical students across the United States to advance their journey toward a career in medicine. This prestigious one-time award, established by Dr. Louis Krenn, a distinguished Family Medicine physician, aims to support the next generation of healthcare professionals who demonstrate a commitment to service, innovation, and compassion. The scholarship, open to students nationwide, invites applicants to share their vision for the future of medicine through a thought-provoking essay. The Dr. Louis Krenn Medical Scholarship seeks to recognize students who view medicine as more than a profession but as a calling to make a meaningful impact. Eligible applicants must be current undergraduate or medical students in the United States actively pursuing a career in medicine, either on a pre-med or medical school track. To apply, candidates are required to submit an original essay of 500–800 words responding to the prompt: 'Medicine is more than a career—it's a calling. What inspired you to pursue a path in healthcare, and how do you hope to shape the future of medicine through your work?' Essays will be evaluated based on originality, depth of reflection, and alignment with the values of service, innovation, and compassion that define Dr. Louis Krenn's legacy. Dr. Louis Krenn, a seasoned physician with over two decades of experience, established this scholarship to inspire and support students who share his dedication to advancing healthcare. Dr. Louis Krenn has held various leadership roles, including Medical Director of Ambulatory Clinical Efficiency, Chief Medical Information Officer, and Director of Telehealth. His work has focused on improving clinical workflows and expanding telehealth access, reflecting his commitment to innovation in patient care. Beyond his clinical and leadership roles, Dr. Louis Krenn is a passionate educator, having mentored countless medical, nursing, and physician assistant students. The scholarship reflects his mission to foster the growth of future physicians who will lead with compassion and drive progress in the medical field. The application process is straightforward, encouraging students to articulate their motivations and aspirations in healthcare. The deadline for submissions is March 15, 2026, with the winner announced on April 15, 2026. The selected recipient will receive a one-time award to support their educational journey. Detailed application instructions and eligibility criteria are available at The Dr. Louis Krenn Medical Scholarship stands as a testament to the importance of nurturing talent in healthcare. By offering this opportunity, the scholarship aims to encourage students to pursue their dreams in medicine while contributing to a brighter, more compassionate future for the industry. Interested applicants are encouraged to visit the official website to learn more and submit their essays. This initiative not only honors Dr. Louis Krenn's contributions to medicine but also invests in the potential of students who will shape the healthcare landscape for years to come. About the Dr. Louis Krenn Medical Scholarship The Dr. Louis Krenn Medical Scholarship is dedicated to supporting undergraduate and medical students pursuing careers in medicine. Founded by Dr. Louis Krenn, the scholarship promotes the values of service, innovation, and compassion in healthcare, aiming to inspire the next generation of physicians to make a lasting impact. For more information, please contact: Spokesperson: Dr. Louis Krenn Organization: Dr. Louis Krenn Scholarship Website: Email: apply@ A photo accompanying this announcement is available at in to access your portfolio
